This audit reflects the national total private sector pharmaceutical market size within South Africa and reflects sales to last point of delivery. It provides anatomical therapeutic classifications by active pharmaceutical ingredient across schedules and assists in evaluating market segmentation, key performance indicators(KPIs), new launches, new launch tracking, molecular class insights and competitive trends. It is a favourite amongst Global Multinationals and is provided in both a Dataview(DV) and Qlikview(QV) format.
Consumer Healthcare (CHC) National
The Consumer Healthcare (CHC) National offering reflects sales to the last point of delivery on a national market level for schedule 2 and below products and includes personal care, patient care and nutritional care. It has the advantage of consumer speak OTC classifications in CHC/OTC categories.
This audit provides state healthcare market intelligence and key insights to tender market trends. It also provides access to tender pricing.
The International Generic Market Segmentation (IGMS) audit assists companies with originator,generic and non-categorised segmentation and evaluating the generic erosion impact, patent protection and expiry, as well as allowing them to differentiate between protected and unprotected markets.It is available for the total private market,pharmacy retail market and dispensing doctor market.
Our offerings into Africa are vast and we are expanding at a fast pace with data offerings spreading the entire geography of Africa.
We currently offer information, technology and services in the following Sub-Saharan African countries: Namibia, Botswana, Zambia, Kenya, Nigeria and Ghana.
Currently we offer 98% coverage of the Total Private Market sales within Namibia, as well as a Dr Specific Model (DUR) which covers 60% of pharmacy filled scripts. Country specific audits are offered in Botswana, Zambia, Kenya, Ghana and Nigeria.
In Northern Africa and French – speaking West Africa our footprint covers the following countries:Morocco, French West Africa (Senegal, Ivory Coast, Cameroon, Mali, Niger, Chad, Burkina Faso, Guinea, Togo, Benin, Gabon, Congo), Egypt, Algeria and Tunisia.
Assists with future forecasting scenarios taking into account macro and micro environmental factors, price adjustments, market and competitor influences.
Fair Market Value
This tool was developed to calculate a fair honorarium for a range of healthcare professionals, taking into account multiple factors.
International Benchmark Pricing - IBP
To benchmark you and your competitors pricing against a basket of countries (i.e.Spain,Canada,New Zealand and Australia) and determine the impact of the IBM pricing legislation on your revenue and bottom line. This service also provides DOH SEPA price application support
Primary Market Research - PMR
We are able to conduct primary market research through face to face, telephonic and digital channels, on various topics that our client’s would like to investigate to uncover key insights into pertinent business questions. Although we do not conduct PMR fieldwork, the team is able to design, collate, interpret and analyse results from PMR conducted by our fieldwork partners.
The Commercial Excellence (CE) suite of products are designed to maximise market opportunity and could be used in isolation or in an interactive approach. They include:
The SA Healthcare Index is a comprehensive view of the SA healthcare and pharmaceutical industry. It provides insight into the overall healthcare environment, pharmaceuticals path to market and segmentation, the NHI (National Health Insurance) and 18-month healthcare and pharmaceutical recap. It is reproduced annually.
Strategic Consulting Services
We are able to provide various other strategic consulting services pending your need. Please enquire with one of our representatives.
Market Prognosis Report
This offering is a strategic market forecasting publication that evaluates the impact of key issues on the pharmaceutical and healthcare industries. It provides insight into the economic and political issues impacting the local pharmaceutical and healthcare industries. As well as identifying the events affecting the market place and provides a 5-year forecast at country, regional and global level.